165 related articles for article (PubMed ID: 3828993)
1. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells.
Taetle R; Honeysett JM
Cancer Res; 1987 Apr; 47(8):2040-4. PubMed ID: 3828993
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
Taetle R; Castagnola J; Mendelsohn J
Cancer Res; 1986 Apr; 46(4 Pt 1):1759-63. PubMed ID: 3004704
[TBL] [Abstract][Full Text] [Related]
3. Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.
White S; Taetle R; Seligman PA; Rutherford M; Trowbridge IS
Cancer Res; 1990 Oct; 50(19):6295-301. PubMed ID: 2400993
[TBL] [Abstract][Full Text] [Related]
4. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
5. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
[TBL] [Abstract][Full Text] [Related]
7. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
Brooks D; Taylor C; Dos Santos B; Linden H; Houghton A; Hecht TT; Kornfeld S; Taetle R
Clin Cancer Res; 1995 Nov; 1(11):1259-65. PubMed ID: 9815920
[TBL] [Abstract][Full Text] [Related]
8. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the binding and growth-supportive ability of mammalian transferrins in human cells.
Penhallow RC; Brown-Mason A; Woodworth RC
J Cell Physiol; 1986 Aug; 128(2):251-60. PubMed ID: 3015988
[TBL] [Abstract][Full Text] [Related]
10. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.
Taetle R; Rhyner K; Castagnola J; To D; Mendelsohn J
J Clin Invest; 1985 Mar; 75(3):1061-7. PubMed ID: 2984253
[TBL] [Abstract][Full Text] [Related]
11. The role of transferrin receptors in hemopoietic cell growth.
Taetle R
Exp Hematol; 1990 May; 18(4):360-5. PubMed ID: 2182335
[TBL] [Abstract][Full Text] [Related]
12. Effects of monoclonal antibodies that block transferrin receptor function on the in vivo growth of a syngeneic murine leukemia.
Sauvage CA; Mendelsohn JC; Lesley JF; Trowbridge IS
Cancer Res; 1987 Feb; 47(3):747-53. PubMed ID: 3802079
[TBL] [Abstract][Full Text] [Related]
13. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
14. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
15. Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence.
Aloj L; Jogoda E; Lang L; Caracò C; Neumann RD; Sung C; Eckelman WC
J Nucl Med; 1999 Sep; 40(9):1547-55. PubMed ID: 10492378
[TBL] [Abstract][Full Text] [Related]
16. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake.
Richardson DR; Baker E
J Cell Physiol; 1994 Oct; 161(1):160-8. PubMed ID: 7929602
[TBL] [Abstract][Full Text] [Related]
17. Transferrin receptor regulation is coupled to intracellular ferritin in proliferating and differentiating HL60 leukemia cells.
Rhyner K; Taetle R; Bering H; To D
J Cell Physiol; 1985 Dec; 125(3):608-12. PubMed ID: 2999167
[TBL] [Abstract][Full Text] [Related]
18. Differential growth-inhibitory effects of gallium on B-lymphocyte lines in high versus low iron concentrations.
Kovar J; Seligman P; Gelfand EW
Cancer Res; 1990 Sep; 50(18):5727-30. PubMed ID: 2393846
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
20. [Interrelation between transferrin receptor expression and intracellular ferritin concentration in leukemia cells and normal marrow cells].
Rhyner K; Taetle R
Schweiz Med Wochenschr; 1986 Oct; 116(43):1484-7. PubMed ID: 3787230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
